{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:50:03Z","timestamp":1782903003146,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science Center in Poland","award":["2017\/25\/N\/NZ5\/02595"],"award-info":[{"award-number":["2017\/25\/N\/NZ5\/02595"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10067-025-07779-0","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T23:15:39Z","timestamp":1763334939000},"page":"163-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum levels of APRIL, BAFF, and IL-10 in systemic lupus erythematosus have limited utility as biomarkers for disease activity or flare prediction"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4094-5961","authenticated-orcid":false,"given":"Gabriela","family":"Rybka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-3557","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Dziedzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-5436","authenticated-orcid":false,"given":"Kazimierz","family":"W\u0119glarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1511-9316","authenticated-orcid":false,"given":"Mamert","family":"Milewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-0248","authenticated-orcid":false,"given":"And\u017celika","family":"Siwiec-Ko\u017alik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-9864","authenticated-orcid":false,"given":"Sylwia","family":"Dziedzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-8103","authenticated-orcid":false,"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0955-1808","authenticated-orcid":false,"given":"Jacek","family":"Musia\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3904-5412","authenticated-orcid":false,"given":"Maciej","family":"Siedlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-2253","authenticated-orcid":false,"given":"Joanna","family":"Kosa\u0142ka-W\u0119giel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"issue":"10441","key":"7779_CR1","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi A, Igel T, Mok CC, Arnaud L (2024) Systemic lupus erythematosus. Lancet 403(10441):2326\u20132338. https:\/\/doi.org\/10.1016\/S0140-6736(24)00398-2","journal-title":"Lancet"},{"issue":"10188","key":"7779_CR2","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T D\u00f6rner","year":"2019","unstructured":"D\u00f6rner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393(10188):2344\u20132358. https:\/\/doi.org\/10.1016\/S0140-6736(19)30546-X","journal-title":"Lancet"},{"key":"7779_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30330","author":"MA Ameer","year":"2022","unstructured":"Ameer MA et al (Oct.2022) An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus. https:\/\/doi.org\/10.7759\/cureus.30330","journal-title":"Cureus"},{"key":"7779_CR4","doi-asserted-by":"publisher","unstructured":"Kosalka J, Jakiela B, Musial J (2015) Changes of memory B- and T-cell subsets in lupus nephritis patients. Folia Histochem Cytobiol VM\/OJS\/J\/43314\u00a0https:\/\/doi.org\/10.5603\/FHC.a2016.0005","DOI":"10.5603\/FHC.a2016.0005"},{"key":"7779_CR5","doi-asserted-by":"publisher","unstructured":"Macedo ACL, Isaac L (2016) Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway.\u00a0Front. Immunol\u00a07.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2016.00055","DOI":"10.3389\/fimmu.2016.00055"},{"issue":"9894","key":"7779_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","volume":"382","author":"M Wahren-Herlenius","year":"2013","unstructured":"Wahren-Herlenius M, D\u00f6rner T (2013) Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382(9894):819\u2013831. https:\/\/doi.org\/10.1016\/S0140-6736(13)60954-X","journal-title":"Lancet"},{"issue":"6","key":"7779_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","volume":"21","author":"GC Tsokos","year":"2020","unstructured":"Tsokos GC (2020) Autoimmunity and organ damage in systemic lupus erythematosus. Nat Immunol 21(6):605\u2013614. https:\/\/doi.org\/10.1038\/s41590-020-0677-6","journal-title":"Nat Immunol"},{"issue":"1","key":"7779_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan L, Lu M-P, Wang J-H, Xu M, Yang S-R (2020) Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr 16(1):19\u201330. https:\/\/doi.org\/10.1007\/s12519-019-00229-3","journal-title":"World J Pediatr"},{"issue":"1","key":"7779_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08830185.2016.1276903","volume":"36","author":"E Samy","year":"2017","unstructured":"Samy E, Wax S, Huard B, Hess H, Schneider P (2017) Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. Int Rev Immunol 36(1):3\u201319. https:\/\/doi.org\/10.1080\/08830185.2016.1276903","journal-title":"Int Rev Immunol"},{"issue":"3","key":"7779_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","volume":"24","author":"FB Vincent","year":"2013","unstructured":"Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F (2013) The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 24(3):203\u2013215. https:\/\/doi.org\/10.1016\/j.cytogfr.2013.04.003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"7779_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11926-012-0258-2","volume":"14","author":"A Davidson","year":"2012","unstructured":"Davidson A (2012) The rationale for BAFF inhibition in systemic lupus erythematosus. Curr Rheumatol Rep 14(4):295\u2013302. https:\/\/doi.org\/10.1007\/s11926-012-0258-2","journal-title":"Curr Rheumatol Rep"},{"key":"7779_CR12","doi-asserted-by":"publisher","unstructured":"Moore KW, De Waal Malefyt R, Coffman RL, O\u2019Garra A (2001) Interleukin-10 and the Interleukin-10 receptor.\u00a0Annu Rev Immunol\u00a019(1):683\u2013765.\u00a0\u00a0https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.683","DOI":"10.1146\/annurev.immunol.19.1.683"},{"key":"7779_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.970906","volume":"13","author":"S Biswas","year":"2022","unstructured":"Biswas S, Bieber K, Manz RA (2022) IL-10 revisited in systemic lupus erythematosus. Front Immunol 13:970906. https:\/\/doi.org\/10.3389\/fimmu.2022.970906","journal-title":"Front Immunol"},{"issue":"3","key":"7779_CR14","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.semarthrit.2019.09.009","volume":"49","author":"M Aringer","year":"2019","unstructured":"Aringer M (2019) EULAR\/ACR classification criteria for SLE. Semin Arthritis Rheum 49(3):S14\u2013S17. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.009","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"7779_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5603\/FHC.2014.0025","volume":"52","author":"K Kaczmarczyk","year":"2014","unstructured":"Kaczmarczyk K, Kosalka J, Soja J, Kuzniewski M, Musial J, Okon K (2014) Renal interstitial mast cell counts differ across classes of proliferative lupus nephritis. Folia Histochem Cytobiol 52(3):218\u2013224. https:\/\/doi.org\/10.5603\/FHC.2014.0025","journal-title":"Folia Histochem Cytobiol"},{"issue":"1","key":"7779_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.advms.2021.01.004","volume":"66","author":"H Szymanik-Grzelak","year":"2021","unstructured":"Szymanik-Grzelak H et al (2021) Retrospective analysis of clinical and pathomorphological features of lupus nephritis in children. Adv Med Sci 66(1):128\u2013137. https:\/\/doi.org\/10.1016\/j.advms.2021.01.004","journal-title":"Adv Med Sci"},{"issue":"8","key":"7779_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/0961203318770006","volume":"27","author":"B Jakiela","year":"2018","unstructured":"Jakiela B et al (2018) Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis. Lupus 27(8):1259\u20131270. https:\/\/doi.org\/10.1177\/0961203318770006","journal-title":"Lupus"},{"issue":"1","key":"7779_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000631","volume":"9","author":"N Aljaberi","year":"2022","unstructured":"Aljaberi N et al (2022) Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus. Lupus Sci Med 9(1):e000631. https:\/\/doi.org\/10.1136\/lupus-2021-000631","journal-title":"Lupus Sci Med"},{"issue":"9957","key":"7779_CR19","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384(9957):1878\u20131888. https:\/\/doi.org\/10.1016\/S0140-6736(14)60128-8","journal-title":"Lancet"},{"issue":"1","key":"7779_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A et al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83(1):15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7779_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","volume":"39","author":"GJ Pons-Estel","year":"2010","unstructured":"Pons-Estel GJ, Alarc\u00f3n GS, Scofield L, Reinlib L, Cooper GS (2010) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39(4):257\u2013268. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.10.007","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"7779_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60121994","volume":"60","author":"J Kosa\u0142ka-W\u0119giel","year":"2024","unstructured":"Kosa\u0142ka-W\u0119giel J et al (2024) Circulating B lymphocyte subsets in patients with systemic lupus erythematosus. Medicina (B Aires) 60(12):1994. https:\/\/doi.org\/10.3390\/medicina60121994","journal-title":"Medicina (B Aires)"},{"issue":"10","key":"7779_CR23","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/art.38074","volume":"65","author":"LM Carter","year":"2013","unstructured":"Carter LM, Isenberg DA, Ehrenstein MR (2013) Elevated serum BAFF levels are associated with rising anti\u2013double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus. Arthritis Rheum 65(10):2672\u20132679. https:\/\/doi.org\/10.1002\/art.38074","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7779_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cellimm.2009.10.004","volume":"261","author":"M Thorn","year":"2010","unstructured":"Thorn M, Lewis RH, Mumbey-Wafula A, Kantrowitz S, Spatz LA (2010) BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion. Cell Immunol 261(1):9\u201322. https:\/\/doi.org\/10.1016\/j.cellimm.2009.10.004","journal-title":"Cell Immunol"},{"issue":"8","key":"7779_CR25","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/art.23678","volume":"58","author":"M Petri","year":"2008","unstructured":"Petri M et al (2008) Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum 58(8):2453\u20132459. https:\/\/doi.org\/10.1002\/art.23678","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7779_CR26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/0961203315608254","volume":"25","author":"DC Salazar-Camarena","year":"2016","unstructured":"Salazar-Camarena DC et al (2016) Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Lupus 25(6):582\u2013592. https:\/\/doi.org\/10.1177\/0961203315608254","journal-title":"Lupus"},{"issue":"8","key":"7779_CR27","first-page":"491","volume":"16","author":"D Elbirt","year":"2014","unstructured":"Elbirt D, Asher I, Mahlab-Guri K, Bezalel-Rosenberg S, Edelstein V, Sthoeger Z (Aug.2014) BLyS levels in sera of patients with systemic lupus erythematosus: clinical and serological correlation. Isr Med Assoc J 16(8):491\u2013496","journal-title":"Isr Med Assoc J"},{"issue":"12","key":"7779_CR28","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1002\/art.11354","volume":"48","author":"W Stohl","year":"2003","unstructured":"Stohl W et al (2003) B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 48(12):3475\u20133486. https:\/\/doi.org\/10.1002\/art.11354","journal-title":"Arthritis Rheum"},{"issue":"1","key":"7779_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000061","volume":"2","author":"I Parodis","year":"2015","unstructured":"Parodis I et al (2015) Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy. Lupus Sci Med 2(1):e000061. https:\/\/doi.org\/10.1136\/lupus-2014-000061","journal-title":"Lupus Sci Med"},{"issue":"9","key":"7779_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/0961203313496302","volume":"22","author":"F Vincent","year":"2013","unstructured":"Vincent F, Northcott M, Hoi A, Mackay F, Morand E (2013) Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus. Lupus 22(9):873\u2013884. https:\/\/doi.org\/10.1177\/0961203313496302","journal-title":"Lupus"},{"issue":"5","key":"7779_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/09612033221086123","volume":"31","author":"S Sari","year":"2022","unstructured":"Sari S et al (2022) The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosus. Lupus 31(5):555\u2013564. https:\/\/doi.org\/10.1177\/09612033221086123","journal-title":"Lupus"},{"issue":"7","key":"7779_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/ard.2004.022491","volume":"64","author":"T Koyama","year":"2005","unstructured":"Koyama T et al (2005) Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis 64(7):1065\u20131067. https:\/\/doi.org\/10.1136\/ard.2004.022491","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"7779_CR33","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/ard.2003.018663","volume":"63","author":"W Stohl","year":"2004","unstructured":"Stohl W et al (2004) Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 63(9):1096\u20131103. https:\/\/doi.org\/10.1136\/ard.2003.018663","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"7779_CR34","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/ard.2008.090928","volume":"68","author":"J Morel","year":"2009","unstructured":"Morel J et al (2009) Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus. Ann Rheum Dis 68(6):997\u20131002. https:\/\/doi.org\/10.1136\/ard.2008.090928","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7779_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.clim.2009.12.012","volume":"135","author":"M Hegazy","year":"2010","unstructured":"Hegazy M, Darwish H, Darweesh H, El-Shehaby A, Emad Y (2010) Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices. Clin Immunol 135(1):118\u2013124. https:\/\/doi.org\/10.1016\/j.clim.2009.12.012","journal-title":"Clin Immunol"},{"issue":"6","key":"7779_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/ar4095","volume":"14","author":"W Treamtrakanpon","year":"2012","unstructured":"Treamtrakanpon W et al (2012) APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis. Arthritis Res Ther 14(6):R252. https:\/\/doi.org\/10.1186\/ar4095","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"7779_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073290","volume":"26","author":"P Richter","year":"2025","unstructured":"Richter P, Macovei LA, Rezus C, Boiculese VL, Buliga-Finis ON, Rezus E (2025) IL-10 in systemic lupus erythematosus: balancing immunoregulation and autoimmunity. IJMS 26(7):3290. https:\/\/doi.org\/10.3390\/ijms26073290","journal-title":"IJMS"},{"issue":"6","key":"7779_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1177\/0961203320913619","volume":"29","author":"V Umare","year":"2020","unstructured":"Umare V, Pradhan V, Dadheech S, Rajadhyaksha A, Ghosh K, Nadkarni A (2020) Clinical implications of IL-10 promoter polymorphisms on disease susceptibility in Indian SLE patients. Lupus 29(6):587\u2013598. https:\/\/doi.org\/10.1177\/0961203320913619","journal-title":"Lupus"},{"issue":"2","key":"7779_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/09629359990586","volume":"8","author":"E Waszczykowska","year":"1999","unstructured":"Waszczykowska E, Robak E, Wozniacka A, Narbutt J, Torzecka JD, Sysa-Jedrzejowska A (1999) Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation. Mediators Inflamm 8(2):93\u2013100. https:\/\/doi.org\/10.1080\/09629359990586","journal-title":"Mediators Inflamm"},{"issue":"4","key":"7779_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/cyto.b.20468","volume":"76B","author":"S Mellor-Pita","year":"2009","unstructured":"Mellor-Pita S et al (2009) Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Cytometry Part B Clinical 76B(4):261\u2013270. https:\/\/doi.org\/10.1002\/cyto.b.20468","journal-title":"Cytometry Part B Clinical"},{"issue":"2","key":"7779_CR41","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2249.2004.02607.x","volume":"138","author":"ER Capper","year":"2004","unstructured":"Capper ER, Maskill JK, Gordon C, Blakemore AIF (2004) Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology? Clin Exp Immunol 138(2):348\u2013356. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02607.x","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"7779_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","volume":"27","author":"H-Y Chun","year":"2007","unstructured":"Chun H-Y et al (2007) Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 27(5):461\u2013466. https:\/\/doi.org\/10.1007\/s10875-007-9104-0","journal-title":"J Clin Immunol"},{"issue":"6","key":"7779_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/biom13060974","volume":"13","author":"A Winikajtis-Burzy\u0144ska","year":"2023","unstructured":"Winikajtis-Burzy\u0144ska A, Brzosko M, Przepiera-B\u0119dzak H (2023) Increased serum interleukin 10 levels are associated with increased disease activity and increased risk of anti-SS-A\/Ro antibody positivity in patients with systemic lupus erythematosus. Biomolecules 13(6):974. https:\/\/doi.org\/10.3390\/biom13060974","journal-title":"Biomolecules"},{"issue":"1","key":"7779_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep34604","volume":"6","author":"J Godsell","year":"2016","unstructured":"Godsell J et al (2016) Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus. Sci Rep 6(1):34604. https:\/\/doi.org\/10.1038\/srep34604","journal-title":"Sci Rep"},{"key":"7779_CR45","doi-asserted-by":"publisher","unstructured":"on behalf of the FHU ACRONIM et al\u00a0(2017) Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review.\u00a0Arthritis Res Ther\u00a019(1):238.\u00a0https:\/\/doi.org\/10.1186\/s13075-017-1442-6","DOI":"10.1186\/s13075-017-1442-6"},{"key":"7779_CR46","doi-asserted-by":"publisher","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, Second edition. Hillsdale, N.J: L. Erlbaum Associates.\u00a0https:\/\/doi.org\/10.4324\/9780203771587","DOI":"10.4324\/9780203771587"}],"updated-by":[{"DOI":"10.1007\/s10067-026-08065-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07779-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07779-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07779-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T01:32:56Z","timestamp":1774661576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07779-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7779"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07779-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,16]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: some data were omitted from the Results section.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10067-026-08065-3","URL":"https:\/\/doi.org\/10.1007\/s10067-026-08065-3","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}